News

The last couple of weeks have been a challenging time for everyone. At Lymphoma Action, our mission still remains the same – to make sure no one faces lymphoma alone.

Obinutuzumab plus bendamustine routinely available on the NHS for people with follicular lymphoma who have not responded to rituximab.

For people with lymphoma during the COVID-19 pandemic.

Specific information on shielding and protecting people considered extremely vulnerable from COVID-19. Those with lymphoma have been identified as one of the extremely vulnerable groups.   

The current situation is understandably causing many people to feel stressed and anxious. This information on the Mind website may be helpful.

New European guidelines give evidence-based recommendations for the diagnosis, treatment and follow-up of people with marginal zone lymphoma.

Dwayne shares his story of mycosis fungoides, a rare type of lymphoma that develops in the skin, and how it impacted him.

NICE approves new, chemotherapy-free treatment option - lenalidomide in combination with rituximab.

There are no specific guidelines for during or after lymphoma treatment - it is recommended you follow the government guidelines.

Results of the LEGEND trial of a lenalidomide-based regimen in DLBCL have been published in the Annals of Haematology.